Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Receivables (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Receivables for 9 consecutive years, with $6.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables fell 28.52% year-over-year to $6.8 million, compared with a TTM value of $6.8 million through Sep 2025, down 28.52%, and an annual FY2025 reading of $6.8 million, changed N/A over the prior year.
  • Receivables was $6.8 million for Q3 2025 at SRx Health Solutions, down from $10.6 million in the prior quarter.
  • Across five years, Receivables topped out at $10.6 million in Q2 2025 and bottomed at $4.3 million in Q2 2024.
  • Average Receivables over 5 years is $6.9 million, with a median of $6.7 million recorded in 2022.
  • The sharpest move saw Receivables tumbled 35.44% in 2023, then skyrocketed 145.04% in 2025.
  • Year by year, Receivables stood at $6.8 million in 2021, then fell by 0.71% to $6.7 million in 2022, then crashed by 35.44% to $4.4 million in 2023, then rose by 23.36% to $5.4 million in 2024, then rose by 27.13% to $6.8 million in 2025.
  • Business Quant data shows Receivables for SRXH at $6.8 million in Q3 2025, $10.6 million in Q2 2025, and $4.8 million in Q1 2025.